How IRB/RA, adaptive design & RBM unlock cross‑border breast trials?
How synchronization of IRB/RA, adaptive design dossiers, and RBM practices is accelerating cross-border breast trials—trends, regulatory updates, and a practical checklist to boost speed and diversity.
Robert Maxwell
Sep 24, 2025
breast cancer trials
stroke trial design
psilocybin therapy trials
diabetic macular edema